Related references
Note: Only part of the references are listed.Correlation between Clinical Pathologic Factors and Activity of 5-FU-Metabolizing Enzymes in Colorectal Cancer
Takeshi Yamada et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2008)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
Molecular basis of antifolate resistance
Yehuda G. Assaraf
CANCER AND METASTASIS REVIEWS (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Nuclear expression of thymidylate synthase in colorectal cancer cell lines and clinical samples
S Bissoon-Haqqani et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer
G Atkin et al.
HUMAN PATHOLOGY (2005)
Role of genomic markers in colorectal cancer treatment
WL Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Relationship between thyrnidylate synthase (TS) genotype and TS expression: A tissue microarray analysis of colorectal cancers
S Popat et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2005)
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity
A Jakobsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review
L Sharp et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Thymidylate synthase protein expression in primary colorectal cancer: Lack of correlation with outcome and response to fluorouracil in metastatic disease sites
PG Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy
RPM Saw et al.
DISEASES OF THE COLON & RECTUM (2003)
Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer
M Gonen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study
CJ Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Role of biological markers in the clinical outcome of colon cancer
O Nanni et al.
BRITISH JOURNAL OF CANCER (2002)
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer
CJ Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Thymidylate synthase expression in colorectal cancer:: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy
D Edler et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
NACS Wong et al.
BRITISH JOURNAL OF CANCER (2001)
Thymidylate synthase expression in stage II and III colon cancer - A retrospective review
A Tomiak et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
Share Paper
